for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-TherapeuticsMD presents positive phase 3 data in two presentations for TX-001HR at ENDO 2017

April 3 (Reuters) - TherapeuticsMD Inc

* TherapeuticsMD presents positive phase 3 data in two presentations for TX-001HR at ENDO 2017

* TherapeuticsMD Inc - Results of replenish trial show positive safety and efficacy of TX-001HR

* TherapeuticsMD - Trial achieved statistically significant, clinically meaningful reduction in both frequency and severity of hot flashes compared to placebo Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up